Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(29%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
43%
Ph phase_4
2
29%
Ph phase_2
1
14%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 4Post-market surveillance
2(33.3%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Completed(1)
Other(3)

Detailed Status

unknown3
Not yet recruiting1
Recruiting1
Active, not recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (16.7%)
Phase 42 (33.3%)
N/A3 (50.0%)

Trials by Status

unknown343%
not_yet_recruiting114%
recruiting114%
active_not_recruiting114%
completed114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DRUG
Total Trials
7